Martin Bæk Blond

Martin Bæk Blond

Guest researcher


  1. 2024
  2. Published

    Albuminuria-lowering effect of adding semaglutide on top of empagliflozin in individuals with type 2 diabetes: A randomized and placebo-controlled study

    Sivalingam, S., Wasehuus, V. S., Rotbain Curovic, V., Blond, Martin Bæk, Hansen, T. W., Persson, F. & Rossing, Peter, 2024, In: Diabetes, Obesity and Metabolism. 26, 1, p. 54-64 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel, superiority, open-label, randomised controlled trial

    Quist, Jonas Salling, Pedersen, H. E., Jensen, M. M., Clemmensen, K. K. B., Bjerre, N., Ekblond, T. S., Uldal, S., Størling, Joachim, Albrechtsen, Nicolai Jacob Wewer, Holst, Jens Juul, Torekov, Signe Sørensen, Nyeland, M. E., Vistisen, D., Jørgensen, M. E., Panda, S., Brock, C., Finlayson, G., Blond, Martin Bæk & Færch, K., 2024, In: The Lancet Healthy Longevity. 5, 5, p. e314-e325 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Extracellular matrix turnover proteins as risk markers in people with type 2 diabetes and microalbuminuria

    Skriver-Møller, A. C., Møller, A. L., Blond, Martin Bæk, Rasmussen, D. G. K., Genovese, F., Reinhard, H., von Scholten, B. J., Jacobsen, P. K., Parving, H. H., Karsdal, M. A., Hansen, Tine Willum & Rossing, Peter, 2024, In: Journal of Diabetes and its Complications. 38, 6, 6 p., 108765.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

ID: 47983803